CRIB (CytoTherapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCRIB (CytoTherapeutics)
Drug Alias Nameencapsulated cells (CytoTherapeutics)stem cells (CytoTherapeutics)NGF (CytoTherapeutics)NGF
ClassificationBiologics
Mechanisms of ActionBeta-nerve growth factor stimulants
TargetsBeta-nerve growth factor
Therapy Area/IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMicrobot Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuroSpheres LtdMicrobot Medical IncGenentech Inc
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease +[4] 

Other Information

ATC CodeN/A
Related LinksN/A